Get In Touch

Breast Reconstruction: A New Way for Breast Cancer Survivors to Renew their Confidence

According to the World Health Organization, in 2018, over 2 million new diagnoses of breast cancer were recorded across the world, going up almost 14% since 2008, and making it the fifth leading cause of cancer deaths among women. At least 1 in 4 women diagnosed with cancer, worldwide, has breast cancer, and such an alarming rise in breast cancer incidence rates has triggered the need for effective treatment and care.

As a result of increasing breast cancer burden, the number of surgical procedures, such as mastectomies, performed across the world, has surged significantly in the past few years. These procedures have a profound impact on the body shape as well as self-esteem, which has ensued developments in breast reconstruction surgeries.

Implant-based breast reconstruction is emerging as one of the most preferred surgical treatment by women undergoing procedures such as mastectomy for the reconstruction of amputated breast(s). In addition, increasing awareness about the safety of breast reconstruction options is encouraging women undergoing mastectomy and other breast cancer surgeries to choose the reconstruction process, either delayed or immediate, causing this market to gain momentum in recent years.

This latest study by Transparency Market Research underlines the notable developments and tracks the advancements in breast cancer treatment and care, to forecast the growth prospects of the breast reconstruction market for the period of 2019-2027. This study also provides actionable insights for stakeholders in the market to sync with the changing trends in the breast cancer care landscape, and subsequently make important strategic business decisions.

global breast reconstruction market infographic

Identify the key factors that will drive your company’s growth. Request a brochure of this report here

Breast Reconstruction Evolves with Technology to Improve Post-surgery Quality of Life

Breast reconstruction has undergone drastic transformations since the first silicone implants of the 1960s, to the emergence of breast implants, tissue expander, acellular dermal matrices (ADMs), and others, in recent years.

Breast reconstruction techniques have evolved a great deal over the past several decades, with options that can be tailored to the individual needs of women suffering from breast cancer. The breast reconstruction market was valued at ~ US$ 1.3 billion as of 2018, and is likely to reach a valuation of ~ US$ 2 billion by 2027. Breast reconstruction surgeries have evolved from being a choice made by only a few to being offered as a routine treatment, performed either post unilateral or bilateral mastectomies. As such, the need for improved benefits and safety of this procedure has only increased.

Technological advancements are likely to incur transformational improvements, not only in the positive outcomes of breast reconstruction surgeries, but also spell advantages for market players in quality-of-life domains of the breast cancer treatment industry. New technologies and innovations that are expected to influence the breast reconstruction markets include 3D printing, which is now being used to create soft absorbable shells with silicon filling, to sync with the specific medical requirements of patients.

Aggressive Use of ADMs: An Emerging Trend in the Breast Reconstruction Market

The breast reconstruction market is gaining momentum with increasing applications silicone and saline breast implants, ADMs, and tissue expanders. The incorporation of breast implants in breast reconstruction surgeries accounted for over two-fifth revenue share of the global market in 2018, and this is expected to remain a prominent trend in the breast reconstruction space in the coming years.

However, ongoing advancements in breast reconstruction procedures that focus on achieving improvements in accuracy in implant positioning and reduction operative time and pain are giving rise to the applications of ADMs in this landscape. The incorporation of innovative imaging technologies in combination with ADMs, shifting from two-step to a single step procedures, is also fostering the growth of this trend in the market, and the adoption of ADMs is likely to increase faster than breast implants in the forecast years.

global breast reconstruction market segmentation

Want to know more such detailed insights of “Breast Reconstruction Market”? Request a PDF sample here

Complications of Implants and Product Recalls to Slow Down Market Growth

Complications associated with breast implant and other products have had a restraining effect on the growth of the breast reconstruction market. These complications include not just the side effects of implants and other products used, but also include Capsular contracture, changes in nipple and breast sensation, scar tissue formation, and rupture with deflation of saline-filled implants. Breast reconstruction complications are not only associated with breast implants, but also ADMs as Hematoma, skin necrosis, infection, and seroma, which are the most commonly reported complications in ADM breast reconstruction surgeries.

Another significant factor restraining the market has been product recalls by various companies, directly impacting their sales and changing their position in the market, both, for a short and a long term period. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) control activities in the breast reconstruction market with high quality standards, stringent approvals and certifications, and guidelines on Good Manufacturing Practices (GMPs). Not following these can result in product recalls.

For instance, in December 2018, Allergan plc – a leading biopharmaceutical company – announced that it has suspended the sales of textured tissue expanders and breast implants in Europe, in addition to withdrawing the remaining supply in the region. The company also declared that, the recall was initiated with a compulsory recall request from Agence Nationale de Sécurité du Médicament (ANSM), which is the French National Agency for Medicines and Health Products Safety, due to the expiration of the company's CE Mark for these products.

Breast Reconstruction Market – Key Strategies to Improve Sales in Developed Countries

As per TMR’s analysis, North America and Europe collectively accounted for ~ 60% of the market share in 2018, and this is likely to remain the same through to 2027. Increasing investments by market leaders in these regions with ongoing clinical trials and research activities are contributing to the development of the breast reconstruction markets in developed regions.

For instance, in July 2018, Sientra, Inc. – a U.S-based medical aesthetics company, announced investments in its new Sientra Lab and Innovation Center of Excellence (SLICE) in California. In March 2018, Establishment Labs SA – a leading medical device and aesthetics company – announced that it has initiated its clinical trial for its Motiva Implants®, which are its breast implant products integrated with innovative aesthetic technologies.

Expanding operations in future? To get the perfect launch ask for a custom report here

Analyst’s View of the Breast Reconstruction Market

Authors of this report on the breast reconstruction market opine that, the market will grow at a steady pace of ~ 5% over the mentioned forecast period. With breast reconstruction procedures on the rise, manufactures will have to focus on expanding their product lines, with better products, around the world, to capitalize on the increasing demand in developed and developing countries, in the foreseeable future.

In addition, while regulatory requirements remain stringent with high standards and strict approvals, market players will have to concentrate on investing heavily in research and clinical trials to introduce safer and innovative solutions for their customers. Enabling surgeons to improve accuracy and precision with convenience during breast reconstruction surgeries and facilitating in enhancing the quality of life for patients post-surgery will help stakeholders upscale their position in the breast reconstruction market

Global Breast Reconstruction Market: Overview

  • The global breast reconstruction market is expected to be valued at ~ US$ 1.4 Bn in 2019, and is projected to expand at a CAGR of ~ 5% from 2019 to 2027. Rise in the prevalence of breast cancer and increase in the number of breast reconstruction procedures are driving the global breast reconstruction market.
  • This report analyzes the current and future scenario of the global breast reconstruction market. Growth of the market is attributed to rise in the prevalence of breast cancer, surge in the demand for breast implants & acellular dermal matrices, and increase in the focus on research and development activities. Additionally, rise in the focus on women’s health and increase in the awareness about breast reconstruction after mastectomy fuel the growth of the global breast reconstruction market.
  • According to Breastcancer.org, in the U.S., nearly 1 in 8 women develop invasive breast cancer, accounting to around 12.4% of cases of breast cancer, globally. Moreover, breast cancer is a common type of cancer diagnosed among women in the U.S. However, product recalls by regulatory authorities and complications due to breast implants & other products are expected to hamper the growth of the global breast reconstruction market.
  • The global breast reconstruction market report comprises an elaborate executive summary, which includes a snapshot that provides information about the various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, end user, and region.
  • A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrices and company profiles along with business overview to understand the competitive landscape in the market. This section also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global breast reconstruction market.

Global Breast Reconstruction Market: Key Segments

  • In terms of product, the global breast reconstruction market has been classified into breast implants, tissue expanders, acellular dermal matrices (ADM), and others. The acellular dermal matrices segment is projected to expand at the fastest CAGR during the forecast period. A large number of manufacturers focusing on the development of dermal matrices for indications such as breast reconstruction and hernia repair is a major factor propelling the segment. The usage of acellular dermal matrices in breast reconstruction by plastic surgeons has increased, especially in developed countries such as the U.S.
  • Based on end user, the global market has been divided into hospitals and ambulatory surgical centers. The ambulatory surgical centers segment is anticipated to experience significant growth in terms of revenue and market share during the forecast period. These segments have been analyzed based on the available products used during breast reconstruction surgeries for the treatment of any breast deformities, to improve esthetic appearance, and the reconstruction of the breast after mastectomy.
  • The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.

Global Breast Reconstruction Market: Regional Outlook

  • In terms of region, the global breast reconstruction market has been segmented into five major regions: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa).
  • The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • The report profiles major players in the global breast reconstruction market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.
  • Players profiled in the report include
    • Allergan
    • Mentor Worldwide LLC (Johnson & Johnson)
    • Sientra, Inc.
    • GC Aesthetics
    • Establishment Labs S.A. 
    • POLYTECH Health & Aesthetics GmbH
    • RTI Surgical, Inc.
    • Groupe Sebbin SAS
    • Integra LifeSciences
    • Wanhe.

[163 Pages Report] Transparency Market Research’s recent report on the breast reconstruction market provides readers an overall market outlook with the help of a comprehensive assessment of the global market scenario. This study on the breast reconstruction market evaluates the historical and current scenario, and includes a forecast from 2019 through to 2027. This report will help readers make important decisions concerning their businesses with the help of exclusive insights into the breast reconstruction market. This report on the breast reconstruction market also has key findings based on the drivers, restraints, opportunities and threats that are likely to make an impact on the growth of the market.

This TMR report on the breast reconstruction market also provides a detailed understanding of the trends and strategies of the frontrunners and key shareholders in the industry. Presented in a clear and sectioned manner, this breast reconstruction market report allows readers to gain an individual understanding of the market.

Key Questions Answered in the Breast Reconstruction Market Report

This report offers extensive data on the breast reconstruction market, on the basis of extensive research on the various factors influencing the development of the market. Key questions answered in this report help companies currently in the breast reconstruction industry looking to establish themselves, create strategies for advancement.

Some of the key questions answered are:

  • What are the drivers and deterrents of the breast reconstruction market?
  • What opportunities exist in the current scenario and are likely to present themselves to stakeholders in the breast reconstruction market?
  • Are there any underlying trends that are expected to drive the breast reconstruction market?
  • How will the breast reconstruction market evolve during the forecast period?
  • Which regions currently dominate the market share of the breast reconstruction market, and is this likely to change?
  • What regional markets in the breast reconstruction market are expected to grow during the forecast period and why?
  • What will be the Y-o-Y growth for the breast reconstruction market?
  • What are the key strategies being implemented by key shareholders in the breast reconstruction market in order to expand their presence?

The report begins with a preface that includes the scope, market segmentation, and research highlights, following, which is an executive summary of the breast reconstruction market. The next section deals with the market overview, product overview, and indicators. The following section deals with the drivers, restraints, and opportunities, which are the market dynamics. This is followed by a detailed segmentation analysis of the breast reconstruction market, an analysis of the growth projections, and a geographical assessment as well.

Research Methodology

The research for this report on the breast reconstruction market was done in four stages: secondary research, primary research, analysis, and conclusion. Sources for the secondary research include, but are not limited to, company annual reports, investor presentations, white papers, research reports, and journals. Primary sources include interviews with opinion leaders, and company websites from both, the supply and demand sides of the breast reconstruction market.

The research uses a triangulation methodology to estimate the size of the breast reconstruction market, with both, a top-down and a bottom-up approach. Detailed assessment of the breast reconstruction market in terms of the competitive scenario is backed by extensive examination of different avenues related to this industry. Analysts’ conclusions in this report on how the market is set to grow are based on qualitative insights from these vetted primary and secondary sources.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Breast Reconstruction Market: Segmentation

This report on the breast reconstruction market categorizes information into 3 segments: product, end user, and region. The underlying trends of the breast reconstruction market and their impact on the evolution of the breast reconstruction market are also discussed.

Product

Breast Implants

Tissue Expanders

Acellular Dermal Matrices

End User

Hospitals

Ambulatory Care Centers

Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Breast Reconstruction Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Breast Reconstruction Market Analysis and Forecast, 2017–2027

5. Key Insights

    5.1. New Product Launch and Regulatory Approvals

    5.2. Novel Technology in Breast Reconstruction

6. Global Breast Reconstruction Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2027

        6.3.1. Breast Implants 

            6.3.1.1. Silicone

            6.3.1.2. Saline 

        6.3.2. Tissue Expanders

        6.3.3. Acellular Dermal Matrices (ADM)

    6.4. Market Attractiveness, by Product

7. Global Breast Reconstruction Market Analysis and Forecast, by End User 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End User, 2017–2027

        7.3.1. Hospitals

        7.3.2. Ambulatory Care Centers

    7.4. Market Attractiveness, by End User 

8. Global Breast Reconstruction Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Market Attractiveness, by Country/Region

9. North America Breast Reconstruction Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product, 2017–2027

        9.2.1. Breast Implants 

            9.2.1.1. Silicone

            9.2.1.2. Saline 

        9.2.2. Tissue Expanders

        9.2.3. Acellular Dermal Matrices (ADM)

    9.3. Market Value Forecast, by End User, 2017–2027

        9.3.1. Hospitals

        9.3.2. Ambulatory Care Centers

    9.4. Market Value Forecast, by Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis 

        9.5.1. By Product

        9.5.2. By End User 

        9.5.3. By Country

10. Europe Breast Reconstruction Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product , 2017–2027

        10.2.1. Breast Implants 

            10.2.1.1. Silicone

            10.2.1.2. Saline 

        10.2.2. Tissue Expanders

        10.2.3. Acellular Dermal Matrices (ADM)

    10.3. Market Value Forecast, by End User, 2017–2027

        10.3.1. Hospitals

        10.3.2. Ambulatory Care Centers

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis 

        10.5.1. By Product

        10.5.2. By End User 

        10.5.3. By Country/Sub-region

11. Asia Pacific Breast Reconstruction Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2027

        11.2.1. Breast Implants 

            11.2.1.1. Silicone

            11.2.1.2. Saline 

        11.2.2. Tissue Expanders

        11.2.3. Acellular Dermal Matrices (ADM)

    11.3. Market Value Forecast, by End User, 2017–2027

        11.3.1. Hospitals

        11.3.2. Ambulatory Care Centers

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis 

        11.5.1. By Product 

        11.5.2. By End User 

        11.5.3. By Country/Sub-region

12. Latin America Breast Reconstruction Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2027

        12.2.1. Breast Implants 

            12.2.1.1. Silicone

            12.2.1.2. Saline 

        12.2.2. Tissue Expanders

        12.2.3. Acellular Dermal Matrices (ADM)

    12.3. Market Value Forecast, by End User, 2017–2027

        12.3.1. Hospitals

        12.3.2. Ambulatory Care Centers

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis 

        12.5.1. By Product 

        12.5.2. By End User 

        12.5.3. By Country/Sub-region

13. Middle East & Africa Breast Reconstruction Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2027

        13.2.1. Breast Implants 

            13.2.1.1. Silicone

            13.2.1.2. Saline 

        13.2.2. Tissue Expanders

        13.2.3. Acellular Dermal Matrices (ADM)

    13.3. Market Value Forecast, by End User, 2017–2027

        13.3.1. Hospitals

        13.3.2. Ambulatory Care Centers

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis 

        13.5.1. By Product 

        13.5.2. By End User 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Share Analysis, by Company (2018)

    14.2. Company Profiles

        14.2.1. Allergan

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Financial Overview

            14.2.1.3. Product Portfolio

            14.2.1.4. SWOT Analysis

            14.2.1.5. Strategic Overview

        14.2.2. Mentor Worldwide LLC (Johnson & Johnson)

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Financial Overview

            14.2.2.3. Product Portfolio

            14.2.2.4. SWOT Analysis

            14.2.2.5. Strategic Overview

        14.2.3. Sientra, Inc.

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Financial Overview

            14.2.3.3. Product Portfolio

            14.2.3.4. SWOT Analysis

             14.2.3.5. Strategic Overview

        14.2.4. Establishment Labs S.A.

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.4.2. Financial Overview

            14.2.4.3. Product Portfolio

            14.2.4.4. SWOT Analysis

            14.2.4.5. Strategic Overview

        14.2.5. POLYTECH Health & Aesthetics GmbH

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Financial Overview

            14.2.5.3. Product Portfolio

            14.2.5.4. SWOT Analysis

            14.2.5.5. Strategic Overview

        14.2.6. RTI Surgical, Inc.

            14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.6.2. Financial Overview

            14.2.6.3. Product Portfolio

            14.2.6.4. SWOT Analysis

            14.2.6.5. Strategic Overview

        14.2.7. Groupe Sebbin SAS

            14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.7.2. Financial Overview

            14.2.7.3. Product Portfolio

            14.2.7.4. SWOT Analysis

            14.2.7.5. Strategic Overview

        14.2.8. Integra LifeSciences

            14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.8.2. Financial Overview

            14.2.8.3. Product Portfolio

            14.2.8.4. SWOT Analysis

            14.2.8.5. Strategic Overview

        14.2.9. Wanhe

            14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.9.2. Financial Overview

            14.2.9.3. Product Portfolio

            14.2.9.4. SWOT Analysis

            14.2.9.5. Strategic Overview

        14.2.10. GC Aesthetics

            14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.10.2. Financial Overview

            14.2.10.3. Product Portfolio

            14.2.10.4. SWOT Analysis

            14.2.10.5. Strategic Overview

List of Tables

Table 01: Product Launch and Regulatory Approvals in Breast Reconstruction Market, by Company
Table 02: Product Launch and Regulatory Approvals in Breast Reconstruction Market, by Company
Table 03: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 04: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by Breast Implants, 2017–2027
Table 05: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 06: Global Breast Reconstruction Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 09: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2017–2027
Table 10: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 11: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 12: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 13: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2017–2027
Table 14: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 15: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 17: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2017–2027
Table 18: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 19: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 21: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2017–2027
Table 22: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by End User, 2017–2027
Table 23: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2027
Table 25: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implant, 2017–2027
Table 26: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by End User, 2017–2027

List of Figures

Figure 01: Global Breast Reconstruction Market Size (US$ Mn) and Distribution (%), by Region, 2019 and 2027
Figure 02: Global Breast Reconstruction Market Value Share, by Product (2018)
Figure 03: Global Breast Reconstruction Market Value Share, by End User (2018)
Figure 04: Global Breast Reconstruction Market Value Share, by Region (2018)
Figure 05: Global Breast Reconstruction Market, By Region (US$ Mn), 2018
Figure 06: Global Breast Reconstruction Market Value (US$ Mn) Forecast, 2017–2027
Figure 07: Global Breast Reconstruction Market Value Share Analysis, by Product, 2017 and 2027
Figure 08: Global Breast Reconstruction Market Revenue (US$ Mn), by Breast Implants, 2017–2027
Figure 09: Global Breast Reconstruction Market Revenue (US$ Mn), by Tissue Expanders, 2017–2027
Figure 10: Global Breast Reconstruction Market Revenue (US$ Mn), by Acellular Dermal Matrices (ADM), 2017–2027
Figure 11: Global Breast Reconstruction Market Revenue (US$ Mn), by Other Products, 2017–2027
Figure 12: Global Breast Reconstruction Market Attractiveness Analysis, by Product, 2019–2027
Figure 13: Global Breast Reconstruction Market Value Share Analysis, by End User, 2018 and 2027
Figure 14: Global Breast Reconstruction Market Revenue (US$ Mn), by Hospitals, 2017–2027
Figure 15: Global Breast Reconstruction Market Revenue (US$ Mn), by Ambulatory Care Centers, 2017–2027
Figure 16: Global Breast Reconstruction Market Attractiveness Analysis, by End User, 2019–2027
Figure 17: Global Breast Reconstruction Market Value Share Analysis, by Region, 2018 and 2027
Figure 18: Global Breast Reconstruction Market Attractiveness Analysis, by Region, 2019–2027
Figure 19: North America Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 20: North America Breast Reconstruction Market Attractiveness Analysis, by Country, 2019–2027
Figure 21: North America Breast Reconstruction Market Value Share Analysis, by Country, 2018 and 2027
Figure 22: North America Breast Reconstruction Market Value Share Analysis, by Product, 2018 and 2027
Figure 23: North America Breast Reconstruction Market Value Share Analysis, by End User, 2018 and 2027
Figure 24: North America Breast Reconstruction Market Attractiveness Analysis, by Product, 2019–2027
Figure 25: North America Breast Reconstruction Market Attractiveness Analysis, by End User, 2019–2027
Figure 26: Europe Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 27: Europe Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 28: Europe Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 29: Europe Breast Reconstruction Market Value Share Analysis, by Product, 2018 and 2027
Figure 30: Europe Breast Reconstruction Market Value Share Analysis, by End User, 2018 and 2027
Figure 31: Europe Breast Reconstruction Market Attractiveness Analysis, by Product, 2019–2027
Figure 32: Europe Breast Reconstruction Market Attractiveness Analysis, by End User, 2019–2027
Figure 33: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 34: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 35: Asia Pacific Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 36: Asia Pacific Breast Reconstruction Market Value Share Analysis, by Product, 2018 and 2027
Figure 37: Asia Pacific Breast Reconstruction Market Value Share Analysis, by End User, 2018 and 2027
Figure 38: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by Product, 2019–2027
Figure 39: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by End User, 2019–2027
Figure 40: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 41: Latin America Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 42: Latin America Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 43: Latin America Breast Reconstruction Market Value Share Analysis, by Product, 2018 and 2027
Figure 44: Latin America Breast Reconstruction Market Value Share Analysis, by End User, 2018 and 2027
Figure 45: Latin America Breast Reconstruction Market Attractiveness Analysis, by Product, 2019–2027
Figure 46: Latin America Breast Reconstruction Market Attractiveness Analysis, by End User, 2019–2027
Figure 47: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 48: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 49: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 50: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by Product, 2018 and 2027
Figure 51: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by End User, 2018 and 2027
Figure 52: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by Product, 2019–2027
Figure 53: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by End User, 2019–2027
Figure 54: Global Breast Reconstruction Market Analysis, by Company Ranking, 2018
Figure 55: Johnson & Johnson Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 56: Johnson & Johnson R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 57: Johnson & Johnson Breakdown of Net Sales, by Region, 2018
Figure 58: Johnson & Johnson Breakdown of Net Sales, by Business Segment, 2018 
Figure 59: Sientra, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 60: Sientra, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 61: Sientra, Inc. Breakdown of Net Sales, by Business Segment, 2018
Figure 62: Allergan Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 63: Allergan R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 64: Allergan Breakdown of Net Sales, by Business Segment (%), 2018
Figure 65: Establishment Labs S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 66: Establishment Labs S.A. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 67: RTI Surgical, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 68: RTI Surgical, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: RTI Surgical, Inc. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 70: RTI Surgical, Inc. Breakdown of Net Sales (%), by Region/Country, 2018
Figure 71: POLYTECH Health & Aesthetics GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 72: Integra LifeSciences Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Integra LifeSciences R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: Integra LifeSciences Breakdown of Net Sales (%), by Business Segment, 2018
Figure 75: Integra LifeSciences Breakdown of Net Sales (%), by Region/Country, 2018

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Breast Reconstruction Market